Home > Publications database > Correction: Infections during AML induction chemotherapy in a contemporary cohort without fluoroquinolone prophylaxis. > print

001     307437
005     20260311105200.0
024 7 _ |a 10.1007/s15010-025-02705-7
|2 doi
024 7 _ |a pmid:41428197
|2 pmid
024 7 _ |a 0300-8126
|2 ISSN
024 7 _ |a 1439-0973
|2 ISSN
037 _ _ |a DKFZ-2025-03036
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Ehrlich, S.
|0 0009-0006-3283-700X
|b 0
245 _ _ |a Correction: Infections during AML induction chemotherapy in a contemporary cohort without fluoroquinolone prophylaxis.
260 _ _ |a München
|c 2026
|b Urban & Vogel
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1773222688_3298569
|2 PUB:(DE-HGF)
|x Erratum/Correction
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a Volume 54, pages 571–572, (2026)
520 _ _ |a Correction: Infection https://doi.org/10.1007/s15010-025-02651-4The original text stated logistic regression was performed, while the original Table 6 showed hazard ratios stemming from an outdated version. Table 6 has been updated to correctly display the results from the Logistic Regression analysis.
536 _ _ |a 899 - ohne Topic (POF4-899)
|0 G:(DE-HGF)POF4-899
|c POF4-899
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Eufinger, J.
|b 1
700 1 _ |a Tahiri, N.
|b 2
700 1 _ |a Jurinovic, V.
|b 3
700 1 _ |a Mansournia, S.
|b 4
700 1 _ |a Kunz, W. G.
|b 5
700 1 _ |a Jung, J.
|b 6
700 1 _ |a Herold, T.
|b 7
700 1 _ |a Subklewe, M.
|b 8
700 1 _ |a Bücklein, V.
|b 9
700 1 _ |a von Bergwelt-Baildon, M.
|0 P:(DE-HGF)0
|b 10
700 1 _ |a Spiekermann, K.
|b 11
773 _ _ |a 10.1007/s15010-025-02705-7
|0 PERI:(DE-600)2006315-5
|p 571–572
|t Infection
|v 54
|y 2026
|x 0300-8126
909 C O |p VDB
|o oai:inrepo02.dkfz.de:307437
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-HGF)0
913 1 _ |a DE-HGF
|b Programmungebundene Forschung
|l ohne Programm
|1 G:(DE-HGF)POF4-890
|0 G:(DE-HGF)POF4-899
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-800
|4 G:(DE-HGF)POF
|v ohne Topic
|x 0
914 1 _ |y 2025
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2024-12-16
|w ger
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2024-12-16
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b INFECTION : 2022
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2024-12-16
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-16
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b INFECTION : 2022
|d 2024-12-16
920 1 _ |0 I:(DE-He78)MU01-20160331
|k MU01
|l DKTK Koordinierungsstelle München
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)MU01-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21